(Q28180783)

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Haemoglobin C protects against clinical Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

PATHOPHYSIOLOGICAL EFFECTS OF SOME ABNORMAL HEMOGLOBINS

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

HbC compound heterozygotes [HbC/Hb Riyadh and HbC/Hb N-Baltimore] with opposing effects upon HbC crystallization

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Solution-active structural alterations in liganded hemoglobins C (beta6 Glu --> Lys) and S (beta6 Glu --> Val)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

A potential determinant of enhanced crystallization of Hbc: spectroscopic and functional evidence of an alteration in the central cavity of oxyHbC

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Intermolecular interactions, nucleation, and thermodynamics of crystallization of hemoglobin C

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Differential pathways in oxy and deoxy HbC aggregation/crystallization

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Homozygous hemoglobin C disease; report of a case with studies on the pathophysiology and neonatal formation of hemoglobin C

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Volume-dependent and NEM-stimulated K+,Cl- transport is elevated in oxygenated SS, SC and CC human red cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Interaction of sickle cell hemoglobin with erythrocyte membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Association of hemoglobin C with erythrocyte ghosts

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

The interaction of hemoglobin O Arab with Hb S and beta+ thalassemia among Israeli Arabs

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

The erythrocyte effects of haemoglobin O(ARAB)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Pitted red cell counts in sickle cell disease. Relationship to age, hemoglobin genotype, and splenic size

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Molecular and cellular pathogenesis of hemoglobin SC disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Frequency of Sickling Disorders in U.S. Blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Treatment of sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Influence of sickle hemoglobinopathies on growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Hb-E in combination with Hb-S and Hb-C in a black family

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Determinants of Haemoglobin Level in Sickle Cell-Haemoglobin C Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

The Clinical Features of Haemoglobin SC Disease in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Ocular findings in hemoglobin SC disease in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Sickle cell disease as a cause of osteonecrosis of the femoral head

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Sickle cell anemia: Erythrokinetics, blood volumes, and a study of possible determinants of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Beta-globin gene haplotype in Hb SC disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Beta-globin gene cluster haplotypes in Hb C heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Sickle-Cell Hemoglobin and Its Relation to Fundus Abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Pain in sickle cell disease. Rates and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Clinical, hematological, and biochemical features of Hb SC disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Acute splenic complications in children with sickle cell-hemoglobin C disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Splenic infarction, splenic sequestration, and functional hyposplenism in hemoglobin S-C disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Fatal pneumococcal septicemia in hemoglobin SC disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Bacteremia in children with sickle hemoglobin C disease and sickle beta(+)-thalassemia: is prophylactic penicillin necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Risk of infection in children with hemoglobin S-beta-thalassemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Hydration of sickle cells using the sodium ionophore Monensin. A model for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Okadaic acid inhibits activation of K-Cl cotransport in red blood cells containing hemoglobins S and C

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Charybdotoxin blocks with high affinity the Ca-activated K+ channel of Hb A and Hb S red cells: individual differences in the number of channels.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Cellular effects of hydroxyurea in Hb SC disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021

A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900003-1

7 January 2021